POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. 

Biotechnology

POINT Biopharma

Joe McCann

Kathryn Simpson

Larry Thompson

Cheryl Roeland

Doug Young

Vincent Jung

William Skarupa

Jessi Cravens

Jazz Braich

Neil Fleshner

Ari Shomair

Bill Demers

Robin Hallett

The Board Members at POINT Biopharma provide strategic oversight and governance, guiding the company’s mission to develop and commercialize radioligand therapies for cancer treatment. They ensure good corporate practices, make high-level decisions, and support executive leadership in achieving clinical and commercial objectives.

Board Members

Leadership Team

Science and Engineering Team

Board Members

About

Team members

Other teams at POINT Biopharma

Leadership Team

Science and Engineering Team